Updated:
Summation Health Ventures
Summation Health Ventures operates as a healthcare-technology focused private equity and venture firm from Long Beach, California.
Summation Health Ventures
Summation Health Ventures operates as a healthcare-technology focused private equity and venture firm from Long Beach, California. The firm's mandate bridges venture-stage risk and private equity discipline, concentrating on companies that combine clinical-grade technology with scalable payer or provider adoption models. The firm typically invests across early-stage venture, late-stage expansion, and growth equity rounds. Its sector focus spans digital health platforms, healthcare enterprise software, and service models that interface directly with health systems or insurers. While specific portfolio names are not publicly enumerated, the investment strategy emphasizes companies where regulatory milestones, such as FDA clearance or CMS reimbursement codes, serve as value-inflection points. Geographic deployment concentrates on North American opportunities. Team size and total committed capital are not publicly disclosed. The firm maintains a low public profile, consistent with an operation that prioritizes technical diligence over marketing visibility. There are no known adjacent philanthropic vehicles, co-investor clubs, or separately branded fund families operating alongside the core investment activities. Summation Health Ventures distinguishes itself structurally through a single-sector, stage-agnostic mandate within healthcare. This permits follow-on capital from seed to pre-IPO without the diversification pressure that generalist technology funds face, though it concentrates portfolio risk in regulatory and policy-driven markets.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Long Beach
Corporate office
Long Beach, CA, United States
Sector focus
Frequently asked questions
What investment stages does Summation Health Ventures target?
The firm deploys capital across the full venture lifecycle, from early-stage startups through expansion and late-stage growth rounds. This stage-agnostic approach allows it to support companies from initial clinical validation through commercialization and scaling.
Does Summation Health Ventures focus exclusively on healthcare?
Yes. Summation Health Ventures is a dedicated healthcare-technology investor. Its mandate concentrates on companies where clinical validation, regulatory approval, and reimbursement pathways are central to the business model, distinguishing it from generalist technology funds.
How does Summation Health Ventures source investment opportunities?
Specific sourcing channels are not publicly detailed. Given the firm's healthcare focus, origination likely depends on domain-expert networks within health systems, clinical research institutions, and payer organizations, though the firm does not publicly describe its deal-flow architecture.
Who leads investment decisions at Summation Health Ventures?
The firm does not publicly name its managing principals or investment committee members. This low public profile suggests a tight partnership structure, but individual decision-makers are not listed in available public records.
Is Summation Health Ventures structured as a venture capital firm or a private equity firm?
The firm is categorized as a private equity firm but operates with a venture capital mandate across early and late stages. This hybrid posture reflects an investment philosophy suited to healthcare, where returns often depend on long-duration regulatory catalysts rather than rapid growth alone.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: